{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:22:44Z","timestamp":1782512564753,"version":"3.54.5"},"reference-count":78,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1517\/17425255.2.3.459","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T10:55:47Z","timestamp":1148986547000},"page":"459-469","source":"Crossref","is-referenced-by-count":25,"title":["Tenofovir disoproxil fumarate for the treatment of HIV infection"],"prefix":"10.1517","volume":"2","author":[{"given":"Paul A","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel E","family":"Gallant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,5,30]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200211010-00001"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2174\/157016206775197664"},{"key":"CIT0003","first-page":"138","volume":"13","author":"GALLANT","year":"2005","journal-title":"Top. HIV Med."},{"key":"CIT0004","first-page":"195","volume":"39","author":"MOORE","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/8394"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.10.2733-2739.2001"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00006"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/135965359900400205","volume":"4","author":"WAINBERG","year":"1999","journal-title":"Antiviral Ther."},{"key":"CIT0009","volume-title":"2nd International Workshop on Clinical Pharmacology of HIV Therapy","author":"KEARNEY","year":"2001"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000167155.44980.e8"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1086\/376991"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000194136.73876.9c"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1086\/432879"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000163933.14649.93"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1089-1095.2004"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005281351"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000176218.40861.14"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/135965350501000405","volume":"10","author":"TORTI","year":"2005","journal-title":"Antivir Ther."},{"key":"CIT0019","volume-title":"Program and abstracts of the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment","author":"VAN","year":"2005"},{"key":"CIT0020","unstructured":"Viread (tenofovir disoproxil fumarate) prescribing information. Gilead Sciences, Foster City, CA, USA (2005)."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2091-2096.2004"},{"key":"CIT0022","volume-title":"7th International Congress on Drug Therapy in HIV Infection.","author":"JOHNSON","year":"2004"},{"key":"CIT0023","unstructured":"Reyataz (atazanavir) prescribing information. Bristol-Myers Squibb, Princeton, NJ, USA (2006)."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1086\/428840"},{"key":"CIT0025","volume-title":"3rd IAS Conference on HIV Pathogenesis and Treatment","author":"MOLINA","year":"2005"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.2.191"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051871"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1086\/498069"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2005.19.135"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.15.9572-9578.2005"},{"key":"CIT0031","volume-title":"11th Conference on Retroviruses and Opportunistic Infections","author":"JEMSEK","year":"2004"},{"key":"CIT0032","first-page":"S172","volume":"9","author":"PODZAMCZER","year":"2004","journal-title":"Antivir. Ther."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1086\/498070"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00006"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200411010-00002"},{"key":"CIT0036","volume-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"MARGOT","year":"2002"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1086\/381784"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3437-3446.2002"},{"key":"CIT0039","volume-title":"8th International HIV Drug Resistance Workshop","author":"BAE","year":"2004"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000163948.62176.e7"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1086\/380398"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00646-7"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.716-723.2002"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1300-1306.2004"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1610-1613.2002"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(03)00005-6"},{"key":"CIT0047","volume-title":"12th Conference on Retroviruses and Opportunistic Infections","author":"RIBERA","year":"2005"},{"key":"CIT0048","volume-title":"12th Conference on Retroviruses and Opportunistic Infections","author":"MILINKOVIC","year":"2005"},{"key":"CIT0049","volume-title":"10th European AIDS Conference","author":"MOYLE","year":"2005"},{"key":"CIT0050","volume-title":"3rd International AIDS Society Conference","author":"MADRUGA","year":"2005"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.04.002"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200403010-00007"},{"key":"CIT0053","volume-title":"10th Conference on Retroviruses and Opportunistic Infections","author":"BLICK","year":"2003"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh658"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1086\/368314"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.03.025"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410027157"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200404090-00019"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.4.415.33182"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1086\/499048"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1086\/432131"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00308.x"},{"key":"CIT0063","volume-title":"FDA Antiviral Drug Products Advisory Committee Meeting, Tenofovir Disoproxil Fumarate","year":"2001"},{"key":"CIT0064","volume-title":"12th Conference on Retrovirus and Opportunistic Infections","author":"POWDERLY","year":"2005"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200203010-00001"},{"key":"CIT0066","volume-title":"11th Conference on Retrovirus and Opportunistic Infections","author":"HAZRA","year":"2004"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000184860.62189.c8"},{"key":"CIT0068","volume-title":"7th International Workshop on Clinical Pharmacology of HIV Therapy","author":"MATHIAS","year":"2006"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1086\/430257"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5239.1197"},{"key":"CIT0071","unstructured":"KEARNEY BP, LIAW S, YALE Ketal.: Pharmacokinetics following single dose administration of tenofovir DF in subjects with renal impairment. [Abstract P4].6th International Congress on Drug Therapy in HIV Infection. Glasgow, UK (2002)."},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.11.3437-3446.2002"},{"key":"CIT0073","first-page":"S28","volume":"7","author":"GARCIA-LERMA","year":"2002","journal-title":"Antiviral Ther."},{"key":"CIT0074","volume-title":"XV International AIDS Conference","author":"MILLER","year":"2005"},{"key":"CIT0075","volume-title":"6th International Congress on Drug Therapy in HIV Infection","author":"MCCOLL","year":"2002"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2179-2184.2002"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200305010-00003"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1086\/381784"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17425255.2.3.459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T15:03:53Z","timestamp":1683471833000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17425255.2.3.459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,30]]},"references-count":78,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,5,30]]},"published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1517\/17425255.2.3.459"],"URL":"https:\/\/doi.org\/10.1517\/17425255.2.3.459","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,30]]}}}